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PMH34 sanoﬁ aventis, Bridgewater, NJ, USA
PMH35 Instituto de Salud Carlos III., Madrid, Spain
PMH36 Janssen-Cilag GmbH, Neuss, Germany
PMH37 Janssen-Cilag GmbH, Neuss, Germany
PMH38 Janssen-Cilag GmbH, Neuss, Germany
PMH39 None
PMH40 Eli Lilly and Company,Windlesham, UK
PMH41 Central University of Venezuela, Caracas,Venezuela
PMH42 Korean Broadcasting System, Seoul, South Korea
PMH43 AstraZeneca Farmacéutica Spain S.A., Madrid, Spain
PMH44 None
PMH45 Janssen-Cilag GmbH, Neuss, Germany
PMH46 Hochschule Neubrandenburg, Neubrandenburg,
Germany
PMH47 Consumer Health Sciences, Princeton, NJ, USA
PMH48 Northern Illinois University, DeKalb, IL, USA
PMH49 Mapi Research Institute, Lyon, , France
PMH50 Maastricht University, Maastricht,The Netherlands
PMH51 Eli Lilly and Co., Indianapolis, IN, USA
PMH52 AstraZeneca, Luton, UK
PMH53 AstraZeneca farmaceutica Spain, Madrid, Spain
PMH54 Wyeth Pharma GmbH, Muenster, Germany
PMH55 H.Lundbeck A/S, Copenhagen, Denmark
PMH56 National Science Council,Taipei,Taiwan
PMH57 Bristol-Myers Squibb, Plainsboro, NJ, USA
PMH58 Janssen-Cilag, Neuss, Germany
PMH59 None
PMH60 H.Lundbeck A/S, Comenhagen, Denmark
PMH61 Janssen Cilag GmbH, Neuss, Germany
PMH62 Pharmerit North America, Bethesda, MD, USA
PMS1 Pﬁzer Spain,Alcobendas, Madrid, Spain
PMS2 None
PMS3 Sanoﬁ-Aventis,Warsaw, Poland
PMS4 Sanoﬁ-Aventis, Mexico, Mexico
PMS5 Pierre Fabre, Boulogne Billancourt, France
PMS6 Pierre Fabre, Boulogne Billancourt, France
PMS7 Pierre Fabre, Boulogne Billancourt, France
PMS8 Pierre Fabre, Boulogne Billancourt, France
PMS9 Pierre Fabre, Boulogne Billancourt, France
PMS10 Pierre Fabre, Boulogne Billancourt, France
PMS11 Pierre Fabre, Boulogne Billancourt, France
PMS12 None
PMS13 Thomson Reuters,Ann Arbor, MI, USA
PMS14 Roche Spa, Monza, Italy
PMS15 Sanoﬁ-Aventis,Warsaw, Poland
PMS16 None
PMS17 York Health Economics Consortium Ltd,York, UK
PMS18 COWI, Copenhagen, Denmark
PMS19 Wyeth Pharmaceuticals, Paris La Défense, France
PMS20 None
PMS21 Bristol-Myers Squibb, Rueil-Malmaison, France
PMS22 None
PMS23 Schering-Plough Corporation, Kenilworth, NJ, USA
PMS24 York Health Economics Consortium Ltd,York, UK
PMS25 Roche Polska,Warsaw, Poland
PMS26 Medtronic Trading NL BV, Heerlen,The Netherlands
PMS27 Clalit Health Services,Tel-Aviv, Israel
PMS28 Bristol-Myers Squibb, Rueil-Malmaison, France
PMS29 Pierre Fabre, Boulogne Billancourt, France
PMS30 Pierre Fabre, Boulogne Billancourt, France
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PMS31 DePuy Orthopaedics, Inc.,Warsaw, IN, USA
PMS32 DePuy Orthopaedics, Inc.,Warsaw, IN, USA
PMS33 Pierre Fabre, Boulogne Billancourt, France
PMS34 Pierre Fabre, Boulogne Billancourt, France
PMS35 Roche Polska,Warsaw, Poland
PMS36 Bristol-Myers Squibb, Rome, Italy
PMS37 Roche Farma, S.A., Madrid, Spain
PMS38 Roche, Stockholm, Sweden
PMS39 Bristol-Myers Squibb, Rome, Italy
PMS40 Novartis, Prague, Czech Republic
PMS41 None
PMS42 Epieconomics Research, Mexico DF, Mexico
PMS43 Centocor Research and Development, Inc., Malvern,
PA, USA
PMS44 Pierre Fabre, Boulogne Billancourt, France
PMS45 Pierre Fabre, Boulogne Billancourt, France
PMS46 MAPI Values, Lyon, France
PMS47 Roche Farma, Madrid, Spain
PMS48 Fondo de Investigacion Sanitaria (FIS)-CIBERESP,
Madrid, Spain
PMS49 University of Athens,Athens, Greece
PMS50 Eli Lilly and Company,Windlesham, UK
PMS51 Thirty-six pharmaceutical companies,Tokyo, Japan
PMS52 PFSA, Castres, France
PMS53 PFSA, Castrers, France
PMS54 TiGenix NV, Leuven, Belgium
PMS55 Thirty-six pharmaceutical companies,Tokyo, Japan
PMS56 Pierre Fabre, Boulogne Billancourt, France
PMS57 UCB, Brussels, Belgium
PMS58 Pierre Fabre, Boulogne Billancourt, France
PMS59 Pierre Fabre, Boulogne Billancourt, France
PMS60 Pierre Fabre, Boulogne-billancourt, France
PMS61 None
PMS62 Bristol-Myers Squibb, Rome, Italy
PMS63 Verigen AG, Leverkusen, Germany
PMS64 Fondo de Investigacion Sanitaria (FIS)-CIBERESP,
Madrid, Spain
PMS65 Centocor Research and Development, Inc., Malvern,
PA, USA
PMS66 MEDTRONIC IBERICA, Madrid, Spain
PMS67 Pﬁzer GmbH, Karlsruhe, Germany
PMS68 None
PMS69 None
PMS70 Wyeth, Collegeville, PA, USA
PMS71 Corvinus University of Bodapest, Budapost,
Hungery
PND1 Abbott Laboratories,Abbott Park, IL, USA
PND2 Heron Evidence Development Ltd., Letchworth
Garden City, UK
PND3 Abbott Laboratories,The Woodlands,TX, USA
PND4 Teva Neuroscience, Kansas City, MO, USA
PND6 Teva Neuroscience, Kansas City, MO, USA
PND7 Erasmus University Rotterdam, Rotterdam, The
Netherlands
PND8 Erasmus University, Rotterdam,The Netherlands
PND9 Bristol Myers Squibb, Paris, France
PND10 Grünenthal, Madrid, Spain
PND11 Johnson and Johnson Pharmaceutical Services,
Beerse, Belgium






PND15 Johnson and Johnson Pharmaceutical Services,
Beerse, Belgium
PND16 None
PND17 University of Montenegro, Podgorica, Montenegro
PND18 Eisai, London, UK
PND19 Biogen Idec, Cambridge, MA, USA
PND20 None
PND21 Charité University Medicine, Berlin, Guam
PND22 Eisai, London, UK
PND23 UCB S.A., Slough, UK
PND24 UCB Pharma, SA,Braine l’Alleud, Belgium
PND25 NOVARTIS FARMACEUTICA S.A, Barcelona, Spain
PND26 None
PND27 None
PND28 Heron Evidence Development, Letchworth Garden
City, UK
PND29 Badalona Serveis Assistencials S.A., Barcelona, Spain
PND30 New BD, São Paulo, Brazil
PND31 Boehringer Ingelheim Limited, Bracknell, UK
PRS1 Badalona Serveis Assistencials SA, Badalona, St. Kitts
and Nevis
PRS2 Université de Montréal, Montreal, QC, Canada
PRS3 None
PRS4 AstraZeneca LP, Wilmington, DE, USA
PRS5 Schering-Plough Ltd.,Welwyn Garden City, UK
PRS7 CHIESI ESPAÑA SA, Barcelona, Spain
PRS8 Pﬁzer Ltd, Helsinki, Finland
PRS9 Bayer Schering Pharma,Wuppertal, Germany
PRS11 AstraZeneca, Lund, Sweden
PRS12 AstraZeneca, Espoo, Finland
PRS13 Pﬁzer Denmark, Copenhagen, Denmark
PRS14 Sanoﬁ aventis de México, Mexico City, Mexico
PRS15 Helmholtz Zentrum Muenchen, German Research




PRS18 Teva Specialty Pharmaceuticals, Horsham, PA, USA
PRS19 Adheris, Inc., Burlington, MA, USA
PRS20 Merck Sharp and Dome, Barcelona, Spain
PRS21 GlaxoSmithKline R&D, London, UK
PRS22 GlaxoSmithKline R&D, London, UK
PRS23 Erasmus MC, iMTA, Rotterdam,The Netherlands
PRS24 AstraZeneca, Madrid, Spain
PRS25 Health System Research Institute, Nonthaburi,
Thailand
PRS26 United BioSource Corporation, Bethesda, MD,
USA
PRS27 Galen Research, Manchester, UK
PRS28 GSK, Marly le Roi, France
PRS29 Laboratorios Pﬁzer, Madrid, Spain
PRS30 Pﬁzer Ltd, Sandwich, UK
PRS31 GSK, Marly le Roi, France
PRS32 GlaxoSmithKline R&D, London, UK
PRS33 None
PRS34 Helmholtz Zentrum Muenchen, German Research
Center for Environmental Health, Neuherberg,
Germany
PRS35 raZeneca Pharmaceuticals,Athens, Greece
PRS36 None




PRS39 Pﬁzer, Paris, , France
PRS40 Pﬁzer Denmark, Copenhagen, Denmark
PRS41 Mapi Research Institute, Lyon, France
PRS42 Pﬁzer Ltd.,Walton Oak, UK
PSS1 Centocor, Inc., Horsham, PA, USA
PSS2 Alcon France, Rueil Malmaison, France
PSS3 Alcon France, Rueil Malmaison, France
PSS4 Alcon France, Rueil Malmaison, France
PSS5 Alcon France, Rueil Malmaison, France
PSS6 Alcon France, Rueil Malmaison, France













PSS23 Astellas Pharma Europe Ltd,, Staines, UK
PSS24 Pﬁzer Ltd.,Tadworth, UK
PSS25 Wyeth Pharmaceuticals, Paris La Defense, France
PSS26 IPF—Institute for Pharmaeconomic Research,
Vienna, Austria
PSS27 Alcon France, Rueil Malmaison, France
PSS28 Mölnlycke Health Care GmbH, Erkrath-
Unterfeldhaus, Germany
PSS29 Basilea Pharmaceutica, Basel, Switzerland
PSS30 Alcon France, Rueil Malmaison, France
PSS31 GlaxoSmithKline Biologicals, Rixensart, Belgium
PSS32 Allergan, Inc., Irvine, CA, USA
PSS33 Allergan, Inc., Irvine, CA, USA
PSS34 Pﬁzer Ltd, Surrey, UK
PSS35 Unidad de Evaluación de Tecnologías Sanitarias,
Madrid, Spain
PSS36 Wyeth Europa, Maidenhead, UK
PSS37 Alcon France, Rueil Malmaison, France
PSS38 Pﬁzer,Alcobendas (Madrid), Spain
PSS39 Schering-Plough S.A., Madrid, Spain
PSS40 None
PSS41 Centocor Research and Development, Inc., Malvern,
PA, USA
PSS42 Pierre Fabre, Boulogne Billancourt, France
PSS43 Pierre Fabre, Boulogne Billancourt, France
PSS44 Pierre Fabre, Boulogne Billancourt, France
PSS45 None
PSS46 None
PSS47 Pierre Fabre, Boulogne Billancourt, France
PSS48 None
PSS49 Novartis Pharmaceutical Corporation, East
Hanover, NJ, USA
PSS50 Schering Plough, Madrid, Spain
PSS51 Alcon France, Rueil Malmaison, France
PSS52 Alcon France, Rueil Malmaison, France
PSS53 Novartis Pharmaceuticals, Barcelona, Spain
PSS54 Wyeth Europe, Maidenhead, UK






PSS57 Merck Serono, London, UK
PSS58 CVderm—Center of Competence in Health
Services Research in Dermatology, Hamburg,
Germany
PSS59 Alcon France, Rueil Malmaison, France
PSS60 Centocor, Inc., Horsham, PA, USA
PSY1 Novo Nordisk A/S,Virum, Denmark
PSY2 Shire HGT, Danderyd, Sweden
PSY3 Sanoﬁ-aventis Korea, Seoul, South Korea
PSY4 Amgen NV, Brussels, Belgium
PSY5 Chulalongkorn University, Bangkok,Thailand
PSY6 University of Tennessee Health Science Center,
Memphis,TN, USA
PSY7 Allergan Pharmaceuticals Inc., Irvine, CA, USA
PSY8 Veneto Region,Verona, Italy
PSY9 Janssen Cilag GmbH, Neuss, Germany
PSY10 Instituto de Salud Carlos III., Madrid, Spain
PSY11 Fourth Hurdle, London, UK
PSY12 Erasmus University, Rotterdam,The Netherlands
PSY14 Roche Mexico, México DF, Mexico
PSY15 United BioSource Corporation, Concord, MA, USA
PSY16 Novo Nordisk A/S, Sorgenfri, Denmark
PSY17 Medtronic Italy, Sesto San Giovanni, Italy
PSY18 Janssen-Cilag AB, Sollentuna, Sweden
PSY19 German Agency for Health Technology Assessment,
Cologne, Germany
PSY20 Eli Lilly Inc, Indianapolis, IN, USA
PSY21 Bayer HealthCare, Barcelona, Spain
PSY22 Medtronic Ibérica, Madrid, Spain
PSY24 Sanoﬁ Pasteur MSD, Brussels, Belgium
PSY25 UCB Celltech, Slough, UK
PSY26 None
PSY27 Pﬁzer Spain, Madrid, Spain
PSY28 Pﬁzer Spain, Madrid, Spain
PSY29 IMS Health HEOR, Munich, Germany
PSY30 Eli Lilly and Company, Inc., Indianapolis, IN, USA
PSY31 None
PSY32 Roche Farmacêutica Química, Lda., Lisbon, Portugal
PSY33 Covance Market Access Services Inc., Gaithersburg,
MD, USA
PSY34 Pﬁzer Pharma GmbH, Karlsruhe, Germany
PSY35 Roche Farma, Madrid, Spain
PSY36 Johnson & Johnson Pharmaceutical Services, Beerse,
Belgium
PSY37 Baxter Healthcare,Wallisellen, Switzerland
PSY38 Consumer Health Sciences, Princeton, NJ, USA
PSY39 sanoﬁ-aventis R&D, Paris, France
PSY40 Pﬁzer,Tadworth, UK
PSY41 Mapi Values, Macclesﬁeld, UK
PSY42 None
PSY43 Amgen, Inc.,Thousand Oaks, CA, USA
PSY44 Novo Nordisk, Copenhagen, Denmark
PSY45 Wyeth Pharmaceuticals, Inc., Collegeville, PA, USA
PSY46 Pﬁzer Pharma GmbH, Karlsruhe, Germany
PSY47 Pﬁzer Spain, Madrid, Spain
PSY48 Bayer Schering Pharma AG, Moscow, Russia
PSY49 Pﬁzer Spain, Madrid, Spain
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PSY50 Johnson & Johnson, Beerse, Belgium
PSY51 Pﬁzer Spain, Madrid, Spain
PSY52 Bayer Schering Pharma AG, Moscow, Russia
PSY53 Novartis Pharmaceuticals, Basel, Switzerland
PSY54 Allergan Pharmaceuticals, Irvine, CA, USA
PSY55 MSD (Thailand), Bangkok,Thailand
PSY56 Abt Bio-Pharma Solutions, Inc., Lexington, MA,
USA
PSY57 Amgen, Paris, France
PSY58 Baxter BioScience,Westlake Village, CA, USA
PSY59 None
PSY60 University of Tennessee Health Science Center,
Memphis,TN
PSY61 PharmIdeas, Buffalo, NY, USA
PSY62 Department of Human Services, Little Rock, AR,
USA
PSY63 Pﬁzer Pharma GmbH, Karlsruhe, Germany
PSY64 Pﬁzer Pharma GmbH, Karlsruhe, Germany
PUK1 Novartis Farmacéutica S.A., Barcelona, Spain
PUK2 Baxter Healthcare Corporation, McGraw Park, IL,
USA
PUK3 Baxter Healthcare Corporation, McGraw Park, IL,
USA
PUK4 Astellas Pharma Spa, Carugate, Italy
PUK5 None
PUK6 MedtronicTrading BV NL,Heerlen,The Netherlands
PUK7 BAP Health Outcomes, Oviedo, Spain
PUK8 Pﬁzer Inc, NewYork, NY, USA
PUK9 Bayer Schering Pharma, Berlin, Germany
PUK10 None
PUK11 Astellas Pharma Europe Ltd, Staines, UK
PUK12 Astellas Pharma Europe Ltd, Staines, UK
PUK13 Hospital Universitario Central De Asturias, Oviedo,
Spain
PUK14 Amgen NV, Brussels, Belgium
PUK15 Roche, Neuilly, France
PUK16 Allergan Inc., Irvine, CA, USA
PUK17 Pﬁzer Inc, NewYork, NY, USA
PUK18 Pﬁzer Inc, NewYork, NY, USA
PUK19 Pﬁzer Inc., Paris, France
PUK20 BAP Health Outcomes, Oviedo, Spain
PUK21 Pﬁzer Inc, NewYork, NY, USA
PUK22 Hospital Universitario Central de Asturias, Oviedo,
Spain
QL1 None
QL2 Mapi Research Institute, Lyon, France
QL3 Mapi Research Trust, Lyon, France
QL4 None
QL5 University Hospital Maastricht, Maastricht, The
Netherlands
QL6 None
QL7 Galen Research, Manchester, UK
QL8 Center on Outcomes, Research and Education,
Evanston, IL, USA
QL9 Invivodata, London, UK
QL10 BAP Health Outcomes, Oviedo, Spain
QL11 UCB, Brussels, Belgium
QL12 Pﬁzer, Sollentuna, Sweden
A668 Disclosure Information
